Substance / Medication

Citalopram hydrobromide

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

247 trials linked to this intervention

247
Total Trials
40
Recruiting
106
With Results

Research Evidence

Published studies and systematic reviews

Sort:
THE USE OF CITALOPRAM HYDROBROMIDE TO MANAGE AGGRESSION IN A MALE CHIMPANZEE ().
Richard Rebecca, Boren Brandon, Becker Jeffrey · J Zoo Wildl Med · 2020
PMID: 31926537Case Report
The impact of borneolum on Citalopram hydrobromide pharmacokinetics and serotonin levels in the hypothalamus of conscious rats.
Wu Jing, Liu Fu-He, Zhao Xiao-Liang et al. · Nat Prod Res · 2025
PMID: 39819229Other
Visualization and quantification of citalopram hydrobromide within highly porous drug products by near-infrared chemical imaging.
Ahola Ilari, Cornett Claus, Rantanen Jukka et al. · Eur J Pharm Sci · 2025
PMID: 40441314Other
Utility of eosin Y as a complexing reagent for the determination of citalopram hydrobromide in commercial dosage forms by fluorescence spectrophotometry.
Azmi Syed Najmul Hejaz, Al-Fazari Ahlam, Al-Badaei Munira et al. · Luminescence · 2015
PMID: 25829234Other
Spectrophotometric determination of citalopram hydrobromide in tablet dosage form using chloranil.
Raza Asad, Ansari Tariq Mahmood · Pak J Pharm Sci · 2014
PMID: 24577911Other
Establishment and Validation of a Transdermal Drug Delivery System for the Anti-Depressant Drug Citalopram Hydrobromide.
Sun Yi-Yang, Ni Ya-Jing, Wang Run-Jia et al. · Molecules · 2024
PMID: 38398519PreclinicalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Citalopram hydrobromide (substance)
SNOMED CT
116521005
UMLS CUI
C0724555

Clinical Data

This intervention maps to 14 entities in the Healos knowledge graph.

8
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
247
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.